Cargando…

SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer

Concurrent chemoradiotherapy is an effective treatment option for patients with low-grade colorectal cancer (CRC) in the local disease stage. At present, the principle of the Taiwan Medical Center is to treat CRC patients with combination radiotherapy and chemotherapy (high-dose 5-FU) for a period o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yueh-Jung, Huang, Siang-Ting, Chang, Ya-Hui, Lin, Shih-Yi, Lin, Weng-Ling, Chen, Ying-Jung, Chien, Shang-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605852/ https://www.ncbi.nlm.nih.gov/pubmed/37886949 http://dx.doi.org/10.3390/cimb45100506

Ejemplares similares

The Expression and Prognostic Value of SUMO1-Activating Enzyme Subunit 1 and Its Potential Mechanism in Triple-Negative Breast Cancer
por: Wang, Qingshui, et al.
Publicado: (2021)

SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma
por: Ong, Jiann Ruey, et al.
Publicado: (2021)

Importin α/β mediates nuclear import of individual SUMO E1 subunits and of the holo-enzyme
por: Moutty, Marie Christine, et al.
Publicado: (2011)

SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies
por: Liang, Ya-Chen, et al.
Publicado: (2016)

Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2016)

Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma
por: Wen, Chen-Yueh, et al.
Publicado: (2022)

Overexpression of Nuclear Protein Kinase CK2 α Catalytic Subunit (CK2α) as a Poor Prognosticator in Human Colorectal Cancer
por: Lin, Kai-Yuan, et al.
Publicado: (2011)

SUMO chain formation relies on the amino-terminal region of SUMO-conjugating enzyme and has dedicated substrates in plants
por: Tomanov, Konstantin, et al.
Publicado: (2018)

High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients
por: Sung, Wen-Wei, et al.
Publicado: (2014)

RAD51 wrestles with SUMO
por: Kee, Younghoon, et al.
Publicado: (2022)

Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer
por: Liu, Xiaoke, et al.
Publicado: (2015)

Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018)

High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
por: Zheng, Lin-Lin, et al.
Publicado: (2023)

A SUMO-dependent feedback loop senses and controls the biogenesis of nuclear pore subunits
por: Rouvière, Jérôme O., et al.
Publicado: (2018)

SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis
por: Tang, Xiaoqian, et al.
Publicado: (2016)

Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer
por: Wang, Ya-Juan, et al.
Publicado: (2022)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
por: Bogachek, Maria V., et al.
Publicado: (2016)

High Expression of FCRLB Predicts Poor Prognosis in Patients With Colorectal Cancer
por: Wang, Xiaopeng, et al.
Publicado: (2022)

Total Chemical Synthesis of SUMO and SUMO‐Based Probes for Profiling the Activity of SUMO‐Specific Proteases
por: Mulder, Monique P. C., et al.
Publicado: (2018)

Regulation of the Expression of DAPK1 by SUMO Pathway
por: Wang, Qingshui, et al.
Publicado: (2019)

High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer
por: Liao, Wen-Ting, et al.
Publicado: (2013)

Association of tricellulin expression with poor colorectal cancer prognosis and metastasis
por: Zhang, Jin-Xiu, et al.
Publicado: (2020)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Adult abuse and poor prognosis in Taiwan, 2000–2015: a cohort study
por: Yu, Pi-Ching, et al.
Publicado: (2022)

Identification of SUMO activating enzyme 1 inhibitors utilizing virtual screening approach
por: Kumar, Ashutosh, et al.
Publicado: (2014)

Negative Regulation of TLR Inflammatory Signaling by the SUMO-deconjugating Enzyme SENP6
por: Liu, Xing, et al.
Publicado: (2013)

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections
por: Mattoscio, Domenico, et al.
Publicado: (2015)

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
por: Du, Li, et al.
Publicado: (2016)

Orthoreovirus outer-fiber proteins are substrates for SUMO-conjugating enzyme Ubc9
por: Yu, Fei, et al.
Publicado: (2016)

Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function
por: Chen, Ling-Chih, et al.
Publicado: (2021)

Sumo-dependent substrate targeting of the SUMO protease Ulp1
por: Elmore, Zachary C, et al.
Publicado: (2011)

Identification of proximal SUMO-dependent interactors using SUMO-ID
por: Barroso-Gomila, Orhi, et al.
Publicado: (2021)

High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Lin, Yueh-Min, et al.
Publicado: (2015)

Cyclin-dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma
por: Deng, Yupeng, et al.
Publicado: (2019)

Elevated Neutrophil-to-Lymphocyte Ratio in Perioperative Periods is Suggestive of Poor Prognosis in Patients with Colorectal Cancer
por: Kim, Jung Hyun, et al.
Publicado: (2021)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vv1lj5f5trona1fkdfvjrvcm9v